@PavlosMsaouel @UTMDAnderson w well done investigator initiated study leveraging EGFR expression in #renalmedullary — panitumumab & Abraxane. Very important life work for a rare cancer.
@ASCO #ASCO26 @OncoAlert @urotoday
@ASCO #ASCO26 @OncoAlert @urotoday
June 1, 2026 at 2:27 PM
@PavlosMsaouel @UTMDAnderson w well done investigator initiated study leveraging EGFR expression in #renalmedullary — panitumumab & Abraxane. Very important life work for a rare cancer.
@ASCO #ASCO26 @OncoAlert @urotoday
@ASCO #ASCO26 @OncoAlert @urotoday